Inactivation ofBrca2cooperates withTrp53R172Hto induce invasive pancreatic ductal adenocarcinomas in mice
Open Access
- 1 June 2011
- journal article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 11 (11) , 959-968
Abstract
An inactivating germline mutation in BRCA2 is the most common known genetic basis for familial pancreatic cancer (FPC), accounting for 5-10% of inherited cases. A genetically engineered mo...Keywords
This publication has 43 references indexed in Scilit:
- Inactivation of Brca2 Promotes Trp53-Associated but Inhibits KrasG12D-Dependent Pancreatic Cancer Development in MiceGastroenterology, 2011
- Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-RasCancer Cell, 2009
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility GeneScience, 2009
- Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult miceProceedings of the National Academy of Sciences, 2008
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- DNA damage signalling guards against activated oncogenes and tumour progressionOncogene, 2007
- Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerGenes & Development, 2006
- Hedgehog/Ras interactions regulate early stages of pancreatic cancerGenes & Development, 2006
- Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseProceedings of the National Academy of Sciences, 2006
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005